Docs overprescribe branded drugs: UK report

Share this article:
The UK government says British doctors are overprescribing branded drugs and that pharma marketers are to blame.

One-fifth of general practitioners surveyed said their prescribing behavior was more influenced by pharma marketing than advice from the nation's National Health Service (NHS), according to a Committee of Public Accounts (CPA) study.

The CPA says NHS spends at least $395 million more than it should because UK physicians prescribe higher-cost branded medications rather than cheaper generic versions to their patients.
 “It's hard to doubt that the blandishments of the pharmaceutical industry are having an effect,” said Edward Leigh, chairman of the CPA in a published report.

Meanwhile, a separate report from British Parliament concluded that the NHS doesn't adopt new, branded medications at a quick enough pace.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.